###begin article-title 0
Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Abstract
###end title 2
###begin p 3
###xml 150 152 150 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 152 155 152 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 525 527 525 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 527 530 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1052 1054 1052 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1054 1057 1054 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1142 1144 1142 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1144 1147 1144 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 504 509 <span type="species:ncbi:10090">mouse</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 1058 1062 <span type="species:ncbi:10090">mice</span>
###xml 1148 1152 <span type="species:ncbi:10090">mice</span>
Dense deposit disease (DDD) is strongly associated with the uncontrolled activation of the complement alternative pathway. Factor H (CFH)-deficient (Cfh-/-) mice spontaneously develop C3 deposition along the glomerular basement membrane (GBM) with subsequent development of glomerulonephritis with features of DDD, a lesion dependent on C3 activation. In order to understand the role of CFH in preventing renal damage associated with the dysregulation of the alternative pathway we administered purified mouse CFH (mCFH) to Cfh-/- mice. 24 h following the administration of mCFH we observed an increase in plasma C3 levels with presence of intact C3 in circulation showing that mCFH restored control of C3 activation in fluid phase. mCFH resulted in the reduction of iC3b deposition along the GBM. The exogenous mCFH was readily detectable in plasma but critically not in association with C3 along the GBM. Thus, the reduction in GBM C3 was dependent on the ability of mCFH to regulate C3 activation in plasma. Western blot analysis of glomeruli from Cfh-/- mice demonstrated the presence of iC3b. Our data show that the C3 along the GBM in Cfh-/- mice is the C3 fragment iC3b and that this is derived from plasma C3 activation. The implication is that successful therapy of DDD is likely to be achieved by therapies that inhibit C3 turnover in plasma.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 207 225 207 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Smith et al., 2007</xref>
###xml 498 516 498 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr">Sethi et al., 2009</xref>
###xml 988 1048 988 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib11 bib12" ref-type="bibr">Linshaw et al., 1987; Marder et al., 1983; Meri et al., 1992</xref>
DDD is an inflammatory renal disease that is strongly associated with complement dysregulation. Around 50% of individuals with DDD will reach end-stage renal failure 10 years after the onset of the disease (Smith et al., 2007). DDD is characterized by electron-dense transformation of the glomerular basement membrane (GBM). The precise composition of the electron-dense areas is unknown but the margins of the deposits contain complement components C3, C5 and C9 in the absence of immunoglobulin (Sethi et al., 2009). DDD is strongly associated with dysregulation of the alternative pathway (AP) of complement activation and specifically with impairment of the function of the plasma protein complement factor H (CFH), the major physiological regulator of the AP. Moreover, DDD can also be triggered by the presence of C3 nephritic factor, an autoantibody that stabilizes the AP C3 convertase (an enzyme complex that cleaves C3), anti-factor H antibodies and dysfunctional C3 molecules (Linshaw et al., 1987; Marder et al., 1983; Meri et al., 1992). The enhanced AP activation in all these situations results in depletion of C3 in plasma.
###end p 6
###begin p 7
###xml 64 69 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 74 78 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 207 244 200 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6 bib20" ref-type="bibr">Dodds et al., 1996; Sahu et al., 1994</xref>
###xml 383 403 376 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">Nishida et al., 2006</xref>
###xml 901 906 894 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1048 1075 1037 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr">Harrison and Lachmann, 1980</xref>
Complement component C3 is a complex glycoprotein consisting of alpha and beta chains containing a thioester bond responsible for its covalent binding to hydroxyl or amine groups present on target surfaces (Dodds et al., 1996; Sahu et al., 1994). C3 can assume four different conformational states governed by thioester bond rearrangement and release of small proteolytic fragments (Nishida et al., 2006). The generation of C3b, via proteolytic cleavage by C3 convertase, initiates a positive feed-back loop that amplifies the activation of the complement cascade. However, this system requires a strict regulatory mechanism to prevent host cell injury and to maintain the normal physiological functions of the complement system. Factor I (CFI) in the presence of its cofactors (CFH, MCP [membrane cofactor protein, CD46] or CR1 [complement receptor one, CD35]) inactivates C3b via cleavage of the C3 alpha-chain, releasing a 17-amino acid peptide termed C3f, forming iC3b. CFI also further degrades iC3b into C3c and C3dg using CR1 as a cofactor (Harrison and Lachmann, 1980).
###end p 7
###begin p 8
###xml 57 59 57 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 177 179 177 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 179 182 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 437 459 437 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">Pickering et al., 2002</xref>
###xml 477 479 477 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 479 482 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 649 671 649 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">Pickering et al., 2002</xref>
###xml 689 691 689 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 691 694 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 728 731 728 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cfi</italic>
###xml 731 734 731 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 887 904 887 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">Rose et al., 2008</xref>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 426 431 <span type="species:ncbi:9606">human</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
Previously, we generated homozygous CFH-deficient mice (Cfh-/-) enabling the contribution of CFH in the development of DDD to be investigated in an in vivo experimental model. Cfh-/- mice developed uncontrolled AP activation with reduced concentration of plasma C3 and presence of C3 breakdown products in circulation. In addition, they developed C3 deposition along the GBM and a glomerular lesion morphologically similar to human DDD (Pickering et al., 2002). Intercrossing Cfh-/- mice with mice deficient in factor B prevented the development of DDD demonstrating that the spontaneous renal disease was dependent on C3 activation through the AP (Pickering et al., 2002). Intercrossing Cfh-/- mice with mice deficient in CFI (Cfi-/-) also prevented the development of DDD demonstrating that the spontaneous renal disease was dependent on the ability of factor I to cleave C3b to iC3b (Rose et al., 2008).
###end p 8
###begin p 9
###xml 202 220 202 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Smith et al., 2007</xref>
###xml 738 760 738 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">Nathanson et al., 2001</xref>
###xml 616 624 <span type="species:ncbi:9606">patients</span>
Current therapeutic approaches to DDD are aimed at slowing the progression of the renal damage by decreasing proteinuria, improving renal hemodynamics and limiting leukocyte infiltration in the kidney (Smith et al., 2007). DDD due to the generation and persistence of autoreactive antibodies (C3Nef and anti-CFH antibodies) would theoretically be amenable to treatments that inhibit the differentiation, maturation, and allostimulatory function of B and T lymphocytes. For individuals with CFH mutations, CFH replacement therapy would seem the most logical approach. In this respect it is notable that CFH-deficient patients with atypical haemolytic uremic syndrome have shown improvement in renal function following infusions of plasma (Nathanson et al., 2001).
###end p 9
###begin p 10
###xml 103 105 103 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 105 108 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 172 174 172 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 688 690 688 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 690 693 690 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 47 53 <span type="species:ncbi:10090">murine</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
Here, we investigated the effects of exogenous murine CFH (mCFH) on plasma and renal C3 regulation in Cfh-/- mice. Administration of mCFH restored plasma C3 regulation in Cfh-/- mice. It also altered the renal C3 staining pattern. Exogenous mCFH resulted in reduction in GBM C3 staining together with the appearance of mesangial and tubulo-interstitial C3 staining. The exogenous mCFH was readily detectable in plasma but could not be detected in association with C3 along the GBM. Thus, the reduction in GBM C3 was dependent on the ability to regulate C3 activation in plasma. Moreover, in this study we provide further evidence that iC3b is the fragment of C3 present along the GBM in Cfh-/- mice.
###end p 10
###begin title 11
Material and methods
###end title 11
###begin title 12
Animals
###end title 12
###begin p 13
###xml 1 3 1 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 39 61 39 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">Pickering et al., 2002</xref>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD11b</italic>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 162 164 162 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD11b</italic>
###xml 172 175 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 211 213 211 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 213 216 213 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD11b</italic>
###xml 226 229 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 122 126 <span type="species:ncbi:10090">Mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
Cfh-/- mice were generated previously (Pickering et al., 2002). CD11b-/- mice were purchased from the Jackson laboratory. Mice deficient for both CFH and CD11b (Cfh-/-CD11b-/-) were generated by inter-crossing Cfh-/- and CD11b-/- mice. All experimental animals were age and sex-matched and were bred on to the C57BL/6 genetic background for at least 10 generations. All experimental procedures were done in accordance with institutional guidelines.
###end p 13
###begin title 14
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
Purified mouse CFH (mCFH)
###end title 14
###begin p 15
###xml 1040 1045 <span type="species:ncbi:9606">human</span>
mCFH was purified from purchased whole serum (Innovative Research, MI, USA) using heparin affinity chromatography. Briefly, serum was treated with 7% polyethylene glycol 8000 (Sigma, Gillingham, UK) on ice. The pellet was dissolved in PBS, dialyzed against Tris-NaCl (Tris 20 mM; NaCl 50 mM pH 7.4) and applied to heparin affinity chromatography (Heparin Sepharosetrade mark 6 Fast Flow, Amersham Pharmacia Biotech, Uppsala, Sweden). After extensive washing, proteins were eluted with a linear salt gradient (75-250 mM NaCl). CFH-containing fractions were pooled, dialyzed against Tris-HCl (20 mM, pH 8.6) and subjected to ion exchange chromatography (DEAE-sepharosetrade mark Fast Flow, GE Healthcare Bio-Sciences AB, Uppsala, Sweden). The column was extensively washed and the bound proteins eluted with a linear salt gradient (0-300 mM NaCl). CFH-containing samples were pooled and dialyzed against PBS. After each chromatography step the samples were checked for the presence of CFH by western blot using polyclonal cross-reactive anti-human CFH (Quidel, CA, USA). The purity of the samples was assessed by Coomassie stained SDS-PAGE gels. Our preparations contained a major protein band at the expected molecular weight position for CFH. Purified CFH samples used in these experiments contained approximately 0.4 mug/mL of lipopolysaccharide (LPS) assayed using Limulus Amebocyte Lysate (LAL) QCL-1000 (Cambrex, MD, USA).
###end p 15
###begin title 16
Tagging mCFH with Alexa Fluor 488
###end title 16
###begin p 17
Purified mCFH was tagged with a fluorescein analogue dye, Alexa 488 by the interaction of tetrafluorophenyl ester moiety with primary amines present in CFH forming stable dye-protein conjugated according to manufacturer's instructions (Invitrogen, Paisley, UK). The efficiency of the tag was measured by spectrophotometry.
###end p 17
###begin title 18
###xml 27 29 27 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Administration of mCFH to Cfh-/- mice
###end title 18
###begin p 19
###xml 256 263 256 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 256 263 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
Animals were intraperitoneally (i/p) injected with 1 mg of purified mCFH preparation or an identical volume of phosphate-buffered saline (PBS). In view of the presence of LPS in the mCFH preparations groups of animals were also injected with purified LPS (E. coli O111:B4, Sigma-Aldrich Co., Gillingham, UK) to identify any LPS-dependent effects. Twenty-four hours after the injection mice were sacrificed and plasma and renal tissue collected.
###end p 19
###begin title 20
Depletion of neutrophils in vivo
###end title 20
###begin p 21
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 41 43 41 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 112 114 112 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2b</sub>
###xml 576 578 575 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2b</sub>
###xml 747 752 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 94 97 <span type="species:ncbi:10116">rat</span>
###xml 120 126 <span type="species:ncbi:10090">murine</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">Mice</span>
###xml 569 572 <span type="species:ncbi:10116">rat</span>
###xml 584 589 <span type="species:ncbi:10090">mouse</span>
###xml 596 600 <span type="species:ncbi:9319">Euro</span>
To achieve neutrophil depletion in vivo Cfh-/- mice were injected i/p at day 0 with 0.5 mg of rat monoclonal IgG2b anti-murine neutrophil antibody (Ly.6G, Santa Cruz Biotechnology, CA, USA). 24 h later mice received either mCFH (1 mg), LPS (0.75 mug) or PBS. Mice were sacrificed on day 2. Blood samples collected before and 24 h after administration of Ly.6G were analysed to confirm successful neutrophil depletion using FACS and peripheral blood film examination. Peripheral blood was collected in 5% EDTA and neutrophils were stained using Phycoerythrin-conjugated rat IgG2b anti-mouse GR-1 (Euro Bioscience GmbH, Friesoythe, Germany) antibody in the presence of a saturating concentration of the monoclonal antibody 2.4G2 which blocks both FcgammaRII and III receptor sites. The results were analyzed with a FACS Calibur instrument (Becton Dickinson, CA, USA). Peripheral blood films were prepared using a drop of peripheral blood collected in EDTA and the neutrophils identified by their characteristic nuclear morphology.
###end p 21
###begin title 22
Plasma mCFH detection
###end title 22
###begin p 23
###xml 92 96 <span type="species:ncbi:9925">goat</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
mCFH in the peripheral blood was detected by western blot using a cross-reactive polyclonal goat antibody against human CFH (Quidel, CA, USA).
###end p 23
###begin title 24
Plasma C3 levels
###end title 24
###begin p 25
###xml 118 140 118 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">Pickering et al., 2007</xref>
###xml 39 43 <span type="species:ncbi:9925">goat</span>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
C3 levels were measured by ELISA using goat anti-mouse C3 antibody (MP Biomedicals, OH, USA) as previously described (Pickering et al., 2007). Results were quantified by reference to a standard curve generated from acute phase sera containing a known quantity of C3 (Calbiochem, CA, USA).
###end p 25
###begin title 26
Analysis of glomerular C3
###end title 26
###begin p 27
###xml 361 365 <span type="species:ncbi:9925">goat</span>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
Glomeruli were isolated from frozen sections using a laser capture microscope (Leica, Wetzlar, Germany) and dissolved in 10% SDS solution containing protease inhibitor cocktail (Sigma-Aldrich Co., Gillingham, UK). Solubilised dissected glomerular tissue was subjected to SDS-PAGE under reduced condition. C3 was then detected by western blot using a polyclonal goat antibody against mouse C3 (MP Biomedicals, CA, USA).
###end p 27
###begin title 28
Histological studies
###end title 28
###begin p 29
###xml 236 258 236 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">Pickering et al., 2006</xref>
###xml 433 437 <span type="species:ncbi:9925">goat</span>
###xml 443 448 <span type="species:ncbi:10090">mouse</span>
###xml 494 498 <span type="species:ncbi:9925">goat</span>
###xml 504 509 <span type="species:ncbi:10090">mouse</span>
Kidneys were fixed in Bouin's solution (Sigma, Gillingham, UK) and sections stained with periodic acid-Schiff reagent. Glomerular histological analysis and neutrophil counting were performed in a blinded manner as previously described (Pickering et al., 2006). Twenty glomeruli were analysed per section. For immunostaining kidneys were snap-frozen and sections cut and fixed in acetone. C3 was detected using either FITC-conjugated goat anti-mouse C3 (MP Biomedicals, CA, USA) or biotinylated-goat anti-mouse C3d (R&D system, MN, USA).
###end p 29
###begin title 30
C3 expression
###end title 30
###begin p 31
###xml 730 743 730 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 752 771 744 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">Arocho et al., 2006</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Total RNA was isolated from whole kidney and liver of mice injected with PBS or mCFH and reverse transcribed into cDNA. Real-time polymerase chain reaction assays were performed on an ABI 7500 Sequence Detection System (Applied Biosystems, Warrington, UK) using SYBER Green (Stratagene, Cambridge, UK). The assay was carried out in triplicate using intron-spanning primer sequences for C3 (forward primer 5'CACCGCCAAGAATCGCTAC-3'; reverse primer 5'GATCAGG TGTTTCAGCCGC-3'), 18S (forward primer 5'CCGCAGCTAGGAATAATGGAA T-3'; reverse primer 5'CGAACCTCCGACTTTCGTTCT-3') and GAPDH (forward primer 5'CACTCTTCCACCTTCGATGC-3'; reverse primer 5'AGGGAGATGCTC AGTG TTGG-3'). The relative expression level of C3 was determined by using the 2-DeltaDeltaCt method (Arocho et al., 2006).
###end p 31
###begin title 32
Statistical analysis
###end title 32
###begin p 33
###xml 17 18 17 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
The Mann-Whitney U test was used for comparison of two groups, whilst for analysis of three or more groups Bonferroni's multiple comparison test was used. Data were analyzed using GraphPad Prism version 3.0 for Windows (GraphPad, San Diego, USA).
###end p 33
###begin title 34
Results
###end title 34
###begin title 35
###xml 58 60 58 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Administration of mCFH regulates plasma C3 activation in Cfh-/- mice
###end title 35
###begin p 36
###xml 162 164 162 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 235 237 235 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 327 349 327 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">Pickering et al., 2002</xref>
###xml 400 402 400 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 402 405 402 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 464 470 464 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 559 561 559 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 561 564 561 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 755 757 754 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 757 760 756 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 790 796 789 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 905 911 904 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 949 954 948 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1084 1089 1079 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1124 1126 1115 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1126 1129 1117 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1159 1165 1150 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 1202 1204 1193 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1204 1207 1195 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1251 1256 1242 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1301 1305 1288 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1341 1346 1325 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1614 1616 1594 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1616 1619 1596 1599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090">mice</span>
###xml 1208 1212 <span type="species:ncbi:10090">mice</span>
###xml 1620 1624 <span type="species:ncbi:10090">mice</span>
To investigate whether the administration of purified mCFH could restore control of AP activation in plasma we assessed the level and state of circulating C3 in Cfh-/- mice after mCFH administration. Plasma C3 levels in unmanipulated Cfh-/- mice are markedly reduced with median levels of approximately 5% of wild-type levels (Pickering et al., 2002). Administration of 1 mg of our purified mCFH to Cfh-/- mice resulted in an increase in plasma C3 levels at 24 h (Fig. 1a). Since our mCFH preparation contained LPS we also assessed plasma C3 levels in three Cfh-/- mice that received 0.75 mug (twice the amount of LPS detected in the administered mCFH preparation) of purified LPS alone. At 24 h these mice had an increase in plasma C3 levels similar to Cfh-/- mice that had received mCFH (Fig. 1a). We next assessed the activation state of the plasma C3 using western blotting under reducing conditions (Fig. 1b). This allowed identification of C3 alpha-chain fragments thereby enabling us to discriminate between intact C3 and its proteolytic fragments (C3b, iC3b and C3dg). Intact alpha-chain was only detectable in the Cfh-/- mice that had received mCFH (Fig. 1b, far right lane). In contrast, in Cfh-/- mice injected with LPS or PBS no intact C3 alpha-chain was present. In these animals, the C3 beta-chain was present together with C3 alpha-chain fragments consistent with ongoing plasma C3 activation. Taken together, this data shows that whilst either LPS or mCFH can increase total antigenic C3 levels in plasma, only mCFH was able to regulate AP activation allowing intact plasma C3 to circulate in the Cfh-/- mice.
###end p 36
###begin title 37
The presence of mCFH influences C3 localization in the kidney
###end title 37
###begin p 38
###xml 15 17 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 70 92 70 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">Pickering et al., 2002</xref>
###xml 188 190 188 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 190 193 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 315 317 315 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 317 320 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 327 333 327 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 515 521 515 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 568 570 568 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 570 573 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 643 645 643 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 645 648 645 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
Unmanipulated Cfh-/- mice have marked deposition of C3 along the GBM (Pickering et al., 2002). Therefore, we next examined whether administration of mCFH could influence glomerular C3 in Cfh-/- mice. 24 h following mCFH administration, we detected striking changes in the glomerular staining pattern for C3 in the Cfh-/- mice (Fig. 2). C3 was hardly detectable on the GBM using the polyclonal anti-mouse C3 antibody. In addition, C3 staining was now evident within the mesangium and within the tubulo-interstitium (Fig. 2). In contrast, the pattern of C3 staining in Cfh-/- mice injected with LPS or PBS did not differ from the unmanipulated Cfh-/- mice.
###end p 38
###begin p 39
###xml 373 375 373 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 375 378 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 418 424 418 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 445 447 445 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 447 450 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 588 594 588 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 747 749 747 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 749 752 749 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 872 874 872 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 874 877 874 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 903 909 903 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 165 170 <span type="species:ncbi:10090">mouse</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 878 882 <span type="species:ncbi:10090">mice</span>
In order to further define the nature of C3 that was detected in the mesangium after administration of mCFH we immunostained kidney sections using a polyclonal anti-mouse C3d antibody. Our data has shown that this antibody does not recognise intact C3 or C3b (Leung at al paper submitted). Using this antibody, GBM C3 staining was detectable to an equivalent intensity in Cfh-/- mice injected with either PBS or mCFH (Fig. 3a). However, in the Cfh-/- mice injected with mCFH, this antibody did not recognize C3 within the mesangium that was evident using the polyclonal anti-C3 antibody (Fig. 3a). This was clearly seen when the two staining images were merged. This showed complete overlap of anti-C3 and anti-C3d glomerular staining pattern in Cfh-/- mice injected with PBS. In contrast, there was no overlap of mesangial and GBM staining patterns in the sections from Cfh-/- mice injected with mCFH (Fig. 3a). This suggested that the nature of the C3 along the GBM was not the same as that of the C3 within the mesangium.
###end p 39
###begin p 40
###xml 56 58 56 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 248 254 248 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 323 325 323 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fi</italic>
###xml 325 328 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 370 375 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 409 414 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 462 464 454 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 464 467 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 536 541 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 555 560 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 581 587 565 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 611 615 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 659 664 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 814 816 791 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fi</italic>
###xml 816 819 793 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 832 836 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 884 889 858 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1081 1086 1051 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1110 1112 1076 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1112 1115 1078 1081 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1327 1329 1293 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1329 1332 1295 1298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 229 234 <span type="species:ncbi:10090">mouse</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 820 824 <span type="species:ncbi:10090">mice</span>
###xml 1116 1120 <span type="species:ncbi:10090">mice</span>
###xml 1333 1337 <span type="species:ncbi:10090">mice</span>
To further investigate this we isolated glomeruli from Cfh-/- mice using laser dissection microscopy. Solublised glomerular isolates were then analysed using SDS-PAGE and C3 detected by western blotting using the polyclonal anti-mouse C3 antibody (Fig. 3b). As controls we loaded in the same gel plasma from wild-type and Cfi-/- mice to indicate the positions of the C3 alpha-chain (wild-type plasma) and the alpha-prime chain of C3b (CFI-deficient plasma). In Cfh-/- glomeruli isolates we could not detect evidence of either intact C3 alpha-chain or the alpha-prime chain of C3b (Fig. 3b). In contrast, the C3 beta-chain was readily detectable together with alpha-chain fragments. This appearance was consistent with the presence of iC3b either alone or in combination with C3dg. In glomerular isolates from the Cfi-/- mice the C3 beta-chain was also readily detectable. However, no alpha-chain fragments were evident indicating that neither iC3b nor C3dg was present in these glomeruli. On these gels there was a faint band running at a similar molecular weight to the intact C3 alpha-chain. Glomeruli from Cfh-/- mice reconstituted with mCFH demonstrated identical C3 fragments as those seen in the animals treated with PBS. Based on the immunostain and western blot analyses we concluded that C3dg bound to the GBM in the Cfh-/- mice was unaffected by the administration of mCFH.
###end p 40
###begin p 41
###xml 113 115 113 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 115 118 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 120 122 120 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fi</italic>
###xml 122 125 122 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 128 145 128 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">Rose et al., 2008</xref>
###xml 517 534 517 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">Rose et al., 2008</xref>
###xml 638 640 638 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 640 643 640 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 645 647 645 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fi</italic>
###xml 647 650 647 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 684 690 684 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 767 769 767 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 769 772 769 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
We have previously shown that GBM C3 staining does not develop in mice with combined deficiency of CFH and CFI (Cfh-/-.Cfi-/-) (Rose et al., 2008). In these animals uncontrolled AP activation occurs but the generated C3b cannot be cleaved further due to the absence of CFI. However, when a source of mouse CFI (serum from mice with combined deficiency of factor H and C3) is administered to these animals not only does plasma C3b cleavage occur but GBM C3 staining becomes evident at 24 h using the anti-C3 antibody (Rose et al., 2008). In view of the present data we next examined the reactivity of the GBM C3 seen in CFI-reconstituted Cfh-/-.Cfi-/- mice with the anti-C3d antibody (Fig. 3c). This showed an identical pattern of staining that seen in unmanipulated Cfh-/- mice, i.e. the GBM C3 was recognised by both antibodies.
###end p 41
###begin title 42
mCFH does not interact with C3 deposited along the GBM
###end title 42
###begin p 43
###xml 143 149 143 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 399 405 399 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 572 574 572 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 574 577 574 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 699 705 699 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 876 878 876 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 878 881 878 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1005 1007 1005 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1007 1010 1007 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1201 1207 1201 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 970 974 <span type="species:ncbi:10090">mice</span>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
24 h after the injection of mCFH, we could still detect CFH in circulation by western blot but the maximal signal was 2 h following injection (Fig. 4a). To check whether the circulating mCFH could interact with glomerular C3 we tagged purified mCFH with Alexa 488 and assessed its distribution 2 h following the injection. We detected tagged CFH in the mesangium and within the tubulo-interstitium (Fig. 4b). This data showed that the administered mCFH did not directly interact with C3 bound on the GBM at this time point. Immunostaining of glomeruli from unmanipulated Cfh-/- mice showed reactivity with a polyclonal anti-CFH antibody in a linear pattern identical to that seen for C3 reactivity (Fig. 4c). We interpreted this reactivity as a consequence of cross-reactivity the anti-CFH antibody with CFH-related proteins that were associated with the GBM-bound C3 in the Cfh-/- mice. Notably, CFH-related protein staining was not detected along the GBM of wild-type mice. In glomerular sections from Cfh-/- mice reconstituted with mCFH a mesangial staining pattern was seen using the polyclonal anti-CFH antibody at 24 h. This pattern was identical to that seen for C3 using the anti-C3 antibody (Fig. 4c). These data suggested that the presence of CFH-related proteins on the GBM is associated with the presence of C3.
###end p 43
###begin title 44
Administration of mCFH did not affect renal synthesis of C3
###end title 44
###begin p 45
###xml 258 260 258 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 260 263 260 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 354 356 354 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 356 359 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
We considered that the appearance of C3 staining within the mesangium after mCFH administration could have been due to glomerular synthesis of C3. To test this hypothesis we performed real time-PCR assay to evaluate C3 mRNA expression in kidney tissue from Cfh-/- mice injected with PBS or mCFH. No difference in C3 mRNA expression was detected between Cfh-/- mice injected with mCFH or PBS (data not shown) suggesting that the mesangial C3 staining was not a consequence of glomerular C3 synthesis.
###end p 45
###begin title 46
###xml 27 29 27 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Glomerular neutrophils in Cfh-/- mice that have received mCFH do not influence glomerular C3 changes and accumulate independently of CD11b (Mac-1)
###end title 46
###begin p 47
###xml 47 49 47 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 129 135 129 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 241 262 241 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr">DiScipio et al., 1998</xref>
###xml 393 395 393 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 395 398 395 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 420 422 420 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 422 425 422 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 431 434 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 649 667 649 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">Carlo et al., 1981</xref>
###xml 735 737 735 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 737 740 737 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 785 791 785 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 936 938 936 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 938 941 938 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 978 984 978 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 145 150 <span type="species:ncbi:9606">Human</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
Neutrophils were observed in the glomeruli of Cfh-/- mice 24 h after the injection of mCFH but not after injection of LPS alone (Fig. 5a and b). Human CFH has been reported to act as an adhesion ligand for neutrophils through CD11b (Mac-1) (DiScipio et al., 1998). To investigate whether the administration of mCFH could be directly involved in neutrophil recruitment we administered mCFH to Cfh-/- mice lacking CD11b (Cfh-/-.CD11b-/-). 24 h after mCFH administration we observed significant glomerular neutrophil influx in these animals demonstrating that the neutrophil influx was independent of CD11b. To test if glomerular neutrophil proteases (Carlo et al., 1981), could influence glomerular C3 staining, we administered mCFH to Cfh-/- mice that had been depleted of neutrophils (Fig. 5c). The change in C3 staining pattern persisted despite neutrophil depletion indicating that neutrophils were not involved in C3 changes in the Cfh-/- mice following mCFH administration (Fig. 5d and e).
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 152 174 152 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">Pickering et al., 2002</xref>
###xml 355 380 355 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr">Kurtz and Schlueter, 2002</xref>
###xml 427 429 427 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 429 432 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 484 506 484 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">Pickering et al., 2002</xref>
###xml 697 699 697 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 699 702 699 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 870 892 870 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">Nathanson et al., 2001</xref>
###xml 1169 1171 1169 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1171 1174 1171 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1391 1393 1391 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1393 1396 1393 1396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 308 315 <span type="species:ncbi:9606">patient</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 1175 1179 <span type="species:ncbi:10090">mice</span>
###xml 1397 1401 <span type="species:ncbi:10090">mice</span>
Complement component C3 appears to be the culprit in DDD as deposition of C3 fragments derived from plasma is required for the renal lesion to develop (Pickering et al., 2002). So far specific therapy for controlling C3 activation remains unavailable. Plasma exchange therapy has been successfully used in a patient with DDD cause by C3 nephritic factor (Kurtz and Schlueter, 2002). Here we investigated the effect of mCFH in Cfh-/- mice which represent an experimental model of DDD (Pickering et al., 2002). Our results showed that the administration of mCFH was able to restore control of C3 activation in plasma, as evidenced by the appearance of intact C3 in the circulation of reconstituted Cfh-/- animals. Consistent with this observation was the reported increase in plasma C3 levels observed in a CFH-deficient individual following the administration of plasma (Nathanson et al., 2001). Furthermore, mCFH administration appeared to stop the deposition of C3 fragments along the GBM. Re-establishing control of alternative pathway activation, even if for a limited amount of time, resulted in an alteration in the pattern of C3 deposition within the kidney. In Cfh-/- mice C3 is normally detected along the GBM and absent within the mesangium and tubulo-interstitium. However, after administration of mCFH we detected C3 staining within both the mesangium and tubulo-interstitium of Cfh-/- mice together with alteration in C3 staining along the GBM.
###end p 49
###begin p 50
###xml 188 210 188 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9" ref-type="bibr">Lenderink et al., 2007</xref>
###xml 231 233 231 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 233 236 233 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 311 313 311 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 313 316 313 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 487 489 487 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 489 492 489 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 540 562 540 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">Alexander et al., 2007</xref>
###xml 793 795 793 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 795 798 795 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
Tubulo-interstitial staining for C3 is present in healthy wild-type mice. It appears to require the ability to activate the alternative pathway as it is absent in factor B-deficient mice (Lenderink et al., 2007). In unmanipulated Cfh-/- mice it is absent while restoring some degree of plasma C3 regulation in Cfh-/- mice through the administration of mCFH we consistently detected C3 staining within the tubulo-interstitium. This data is consistent with renal transplant studies where Cfh-/- kidneys have been placed into wild-type hosts (Alexander et al., 2007). In these experiments complete resolution of GBM C3 staining was seen with concomitant appearance of normal tubulo-interstitial C3 staining pattern. When the opposite experiment was performed, i.e. wild-type kidneys placed into Cfh-/- hosts, tubulo-interstitial C3 staining within the wild-type transplanted kidney was lost. Thus, this data together with our results suggest that the normal C3 staining within the tubulo-interstitium is dependent on the presence of intact circulating C3.
###end p 50
###begin p 51
###xml 45 47 45 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 466 468 466 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fi</italic>
###xml 468 471 468 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 621 638 621 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">Rose et al., 2008</xref>
###xml 763 780 763 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">Rose et al., 2008</xref>
###xml 969 971 969 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fi</italic>
###xml 971 974 971 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1382 1384 1382 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1384 1387 1384 1387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1542 1544 1542 1544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fi</italic>
###xml 1544 1547 1544 1547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2119 2121 2119 2121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 2121 2124 2121 2124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2403 2420 2403 2420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr">West et al., 2001</xref>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1228 1232 <span type="species:ncbi:10090">mice</span>
###xml 1388 1392 <span type="species:ncbi:10090">mice</span>
###xml 1548 1552 <span type="species:ncbi:10090">mice</span>
###xml 2125 2129 <span type="species:ncbi:10090">mice</span>
###xml 2302 2307 <span type="species:ncbi:9606">human</span>
The presence of mesangial C3 was evident in Cfh-/- mice reconstituted with mCFH using a polyclonal anti-C3 antibody. However, this staining was not detectable using a polyclonal anti-C3d antibody. Previous experimental animal data has suggested that, in situations where there is dysregulation of the alternative pathway activation, the nature of the C3 activation fragment produced in plasma is important in determining where it deposits within the glomerulus. In Cfi-/- mice excessive production of activated C3b occurs and the absence of CFI prevents further degradation of C3b to its metabolites: iC3b, C3c and C3dg (Rose et al., 2008). In these animals abnormal mesangial C3 staining is evident using the same polyclonal anti-C3 antibody used in this study (Rose et al., 2008). However, this mesangial C3 does not react with the polyclonal anti-C3d antibody (Leung et al., unpublished data). Taken together with our laser capture analysis of C3 in glomeruli from Cfi-/- mice, this data indicated that the anti-C3d antibody, in contrast to the anti-C3 antibody, could not recognise C3b in renal sections. Furthermore, when the anti-C3d antibody was used in a sandwich ELISA it failed to detect intact plasma C3 in wild-type mice (Leung et al., unpublished data). Based on lack of reactivity with the anti-C3d antibody we postulated that the mesangial C3 reactivity observed in Cfh-/- mice reconstituted with mCFH could represent (1) intact C3 derived from local synthesis, (2) C3b derived from the circulation (analogous to that seen in Cfi-/- mice) or (3) C3c which lacking the C3dg fragment would be expected not to react with anti-C3d antibody. We considered the first possibility unlikely since we could not detect any evidence of an increase in renal C3 synthesis following administration of mCFH by RT-PCR. However, it could be that our quantitative C3 RT-PCR analysis using kidney tissue may not have been sensitive enough to detect a minor increase in mesangial C3 synthesis. We excluded the second possibility since we could not detect evidence of C3b in either the plasma or laser dissected glomeruli of Cfh-/- mice reconstituted with mCFH. It therefore seemed most likely that the mesangial C3 in the reconstituted animals represented the C3c fragment. This is consistent with data from human DDD studies that have shown that paramesangial C3 deposits appear to be comprised of C3c only (West et al., 2001).
###end p 51
###begin p 52
###xml 96 98 96 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 98 101 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 151 153 151 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 258 264 258 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 361 365 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 386 391 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 409 415 402 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 513 515 506 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 515 518 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 796 801 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1641 1643 1630 1632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1643 1646 1632 1635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2151 2167 2140 2156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">Sim et al., 1993</xref>
###xml 2587 2605 2576 2594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">Carlo et al., 1981</xref>
###xml 2928 2973 2917 2962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3 bib5" ref-type="bibr">Avery and Gordon, 1993; DiScipio et al., 1998</xref>
###xml 3056 3058 3045 3047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 3058 3061 3047 3050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
Our data also showed differences in the GBM reactivity using the two anti-C3 antibodies in the Cfh-/- mice reconstituted with mCFH. In unmanuipulated Cfh-/- mice linear capillary wall staining for C3 was evident using both the anti-C3 and anti-C3d antibody (Fig. 3a). Analysis of glomerular C3 using laser capture microscopy demonstrated the presence of the C3 beta-chain together with alpha-chain fragments (Fig. 3b), an appearance consistent with iC3b. This demonstrated that iC3b is present within the GBM of Cfh-/- mice. The reactivity also suggested that the anti-C3d antibody could recognise iC3b in addition to C3dg. However, we could not exclude that C3dg in addition to iC3b was present along the GBM since the molecular weight of C3dg (38 kDa) is similar to the molecular weight of the alpha-chain fragments of iC3b (43 and 40 kDa). Hence the presence of both iC3b and C3dg along the GBM would have given the same bands on the glomerular western blot analysis as iC3b alone. Following administration of mCFH there was a striking reduction in GBM reactivity using the anti-C3 antibody whereas the intensity of GBM staining using the anti-C3dg antibody remained unchanged. This differential reactivity indicated that the nature of the C3 along the GBM had changed. The lack of change in the intensity of the anti-C3d reactivity could indicate that mCFH administration did not alter the degree of GBM associated C3d. However, this would not explain the concomitant appearance of C3c within the mesangium following mCFH administration. An alternative possiblity was that following temporary restoration of plasma C3 regulation in the Cfh-/- animals reconstituted with mCFH iC3b bound along the GBM was cleaved into C3dg and C3c fragments, the former remaining bound to the GBM and the latter removed to mesangial areas. Initially we considered this processing could be mediated by exogenous mCFH together with CFI. However, our data showed that the injected mCFH did not co-localize with iC3b along the GBM. Furthermore, CFH is not considered to be able to act as a cofactor for the CFI-mediated cleavage of iC3b under physiological conditions (Sim et al., 1993). Therefore, it appeared that if further processing of GBM-bound C3 occurred it was not due to a direct effect of the injected mCFH. Administration of CFH also induced migration of neutrophils in to the glomeruli. We considered that these could be involved in the cleavage of iC3b along the GBM. Bound iC3b is highly sensitive to proteases and neutrophil elastase are extremely active in cleaving iC3b to C3c and C3dg (Carlo et al., 1981). However, the appearance of mesangial C3 reactivity persisted despite neutrophil depletion. The explanation for the glomerular neutrophil influx seen in mCFH-reconstituted animals is not clear. CFH could theoretically facilitate the migration of neutrophils via interaction with the integrin CD11b independently of iC3b (Avery and Gordon, 1993; DiScipio et al., 1998). However, glomerular neutrophils still appeared following mCFH adminstration in Cfh-/- animals that lacked CD11b. We were unable to test whether neutrophil influx developed using mCFH that was completely free of LPS so it remains possible that this phenomenon was a synergistic effect of mCFH and LPS.
###end p 52
###begin p 53
###xml 132 134 132 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 134 137 134 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 663 682 663 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">Murphy et al., 2002</xref>
###xml 851 870 851 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">Murphy et al., 2002</xref>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 480 488 <span type="species:ncbi:9606">patients</span>
We also considered the possibility that CFH-related proteins could be involved in the processing of GBM-bound C3. In unmanipulated Cfh-/- mice we detected capillary wall staining pattern using a polyclonal anti-CFH antibody. As these animals lack CFH this reactivity represented the presence of CFH-related proteins (CFHRs) along the GBM, co-localizing with C3. It is noteworthy here that the presence of the CFHR protein, CFHR-5, has been detected in 92 out of 100 biopsies from patients with glomerular sclerosis from all causes, including diabetic nephropathy, focal glomerular sclerosis and advanced proliferative glomerular diseases with areas of sclerosis (Murphy et al., 2002). In all of them CFHR-5 had a similar pattern of distribution to C3. Furthermore, CFHR-5 was strongly associated with complement-containing glomerular immune deposits (Murphy et al., 2002).
###end p 53
###begin p 54
In summary, the administration of mCFH primarily restored plasma C3 regulation and this subsequently favored the clearance of the GBM-bound iC3b. Our data suggested that, whilst iC3b within the GBM was removed, C3dg remained bound to the GBM. We were unable to detect localisation of the exogenous mCFH with GBM C3 indicating that the alteration in GBM C3 was not due to a direct effect of mCFH. This processing of GBM C3 could be mediated by CFH-related proteins. We propose that that CFH acts primarily to down-regulate C3 activation in plasma. Within the GBM the CFH-related proteins are important in the intra-renal physiological processing of any deposited iC3b. However, their function is overridden when excessive iC3b is produced in circulation that accumulates along the GBM. Our data reinforce the concept that DDD therapy should be directed at interventions that restore plasma C3 regulation.
###end p 54
###begin title 55
Acknowledgements
###end title 55
###begin p 56
We thank the staff of the Biological Services Unit at Imperial College, London, United Kingdom for the care of the animals involved in this study and Dr. Jacques Behmoaras for technical help. DP-C was funded by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and a Marie Curie Fellowship (IMDEMI, 005632). MCP is a Welcome Trust Senior Fellow in Clinical Science (WT082291MA).
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
Mouse podocyte complement factor H: the functional analog to human complement receptor 1
###end article-title 58
###begin article-title 59
Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts
###end article-title 59
###begin article-title 60
###xml 40 45 <span type="species:ncbi:9606">human</span>
Characterization of factor H binding to human polymorphonuclear leukocytes
###end article-title 60
###begin article-title 61
Cleavage of membrane bound C3bi, an intermediate of the third component of complement, to C3c and C3d-like fragments by crude leucocyte lysosomal lysates and purified leucocyte elastase
###end article-title 61
###begin article-title 62
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaMbeta2 (CD11b/CD18)
###end article-title 62
###begin article-title 63
###xml 56 61 <span type="species:ncbi:9606">human</span>
The reaction mechanism of the internal thioester in the human complement component C4
###end article-title 63
###begin article-title 64
###xml 54 59 <span type="species:ncbi:9606">human</span>
The physiological breakdown of the third component of human complement
###end article-title 64
###begin article-title 65
Management of membranoproliferative glomerulonephritis type II with plasmapheresis
###end article-title 65
###begin article-title 66
###xml 94 98 <span type="species:ncbi:10090">mice</span>
The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy
###end article-title 66
###begin article-title 67
###xml 44 50 <span type="species:ncbi:9606">infant</span>
Hypocomplementemic glomerulonephritis in an infant and mother Evidence for an abnormal form of C3
###end article-title 67
###begin article-title 68
An inherited defect in the C3 convertase, C3b,Bb, associated with glomerulonephritis
###end article-title 68
###begin article-title 69
Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis
###end article-title 69
###begin article-title 70
###xml 49 54 <span type="species:ncbi:9606">human</span>
Factor H-related protein-5: a novel component of human glomerular immune deposits
###end article-title 70
###begin article-title 71
Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency
###end article-title 71
###begin article-title 72
Structural transitions of complement component C3 and its activation products
###end article-title 72
###begin article-title 73
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H
###end article-title 73
###begin article-title 74
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice
###end article-title 74
###begin article-title 75
Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains
###end article-title 75
###begin article-title 76
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice
###end article-title 76
###begin article-title 77
###xml 57 62 <span type="species:ncbi:9606">human</span>
Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation
###end article-title 77
###begin article-title 78
Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway
###end article-title 78
###begin article-title 79
Complement factor I and cofactors in control of complement system convertase enzymes
###end article-title 79
###begin article-title 80
New approaches to the treatment of dense deposit disease
###end article-title 80
###begin article-title 81
Composition of nephritic factor-generated glomerular deposits in membranoproliferative glomerulonephritis type 2
###end article-title 81
###begin p 82
###xml 31 33 31 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 96 98 96 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 98 101 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 356 358 354 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 358 361 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
Plasma C3 levels and state in Cfh-/- mice injected with purified mCFH. (A) Plasma C3 levels in Cfh-/- mice 24 h after the injection of PBS, 1 mg of purified mouse factor H or 0.75 mug of LPS. Wild-type C3 control level in this ELISA was 387 mug/ml. Columns denote median values with standard deviation (B) Western blot for mouse C3 using EDTA plasma from Cfh-/- mice 24 h after the injection of PBS, mCFH (1 mg) or LPS (0.75 mug) under reducing conditions. The EDTA plasma dilution used for all the samples was 1 in 100. LPS: lipopolysaccharide, PBS: phosphate-buffered saline.
###end p 82
###begin p 83
###xml 19 21 19 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 187 189 187 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 280 282 279 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 282 285 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 468 470 467 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 470 473 469 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 594 596 593 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 596 599 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
Renal C3 stain in Cfh-/- mice 24 h after the injection of purified mCFH. Kidney sections were stained for C3 using polyclonal anti-mouse C3. Linear capillary wall staining is evident in Cfh-/- mice injected with PBS or 0.75 mug of LPS. In contrast, mesangial staining is seen in Cfh-/- mice 24 h after injection of 1 mg of mCFH. C3 staining is present along Bowman's capsule and within tubulo-interstitium of wild-type mice. Tubulo-interstitial staining is absent in Cfh-/- mice injected with PBS or LPS. However, after administration of mCFH, tubulo-interstial staining is now evident in the Cfh-/- animals. Original magnification 40x. WT: wild-type.
###end p 83
###begin p 84
###xml 326 328 326 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 328 331 328 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 767 769 767 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fi</italic>
###xml 769 772 769 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 775 777 775 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 777 780 777 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 785 787 785 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 862 867 862 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 879 884 875 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 907 911 899 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 968 970 957 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fi</italic>
###xml 970 973 959 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1047 1052 1036 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1080 1084 1065 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1108 1110 1090 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1110 1113 1092 1095 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1178 1183 1160 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1232 1234 1210 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fi</italic>
###xml 1234 1237 1212 1215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1324 1326 1302 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 1326 1329 1304 1307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1331 1333 1309 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fi</italic>
###xml 1333 1336 1311 1314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
###xml 178 183 <span type="species:ncbi:10090">mouse</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 408 413 <span type="species:ncbi:10090">mouse</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 974 978 <span type="species:ncbi:10090">mice</span>
###xml 1114 1118 <span type="species:ncbi:10090">mice</span>
###xml 1277 1281 <span type="species:ncbi:10090">mice</span>
Nature of C3 bound to the glomeruli 24 h after the administration of mCFH. (A) Kidney sections were stained for C3 using polyclonal anti-mouse C3d (red stain) or polyclonal anti-mouse C3 (green stain) antibodies. In the mice injected with PBS linear capillary wall staining was evident using both antibodies. However, in the Cfh-/- mice injected with mCFH a mesangial staining pattern was evident using anti-mouse C3 antibody whilst the linear capillary wall staining pattern remained unchanged with the anti-C3d antibody. The merged images showed that the areas of mesangial reactivity did not co-stain with the anti-C3d. Original magnification 40x. (B) Western blot analysis of C3 under reducing conditions using solubilised laser dissected glomerular tissue from Cfi-/-, Cfh-/- or Cfh-/- mice injected with mCFH. To demonstrate the positions of the intact C3 alpha-chain, the alpha' chain of C3b and the beta-chain of C3 plasma from both wild-type (intact C3) and Cfi-/- mice (in which all C3 is circulating as C3b) was also run on the gel. C3 alpha-chain fragments and the C3 beta-chain were evident in Cfh-/- mice with or without the administration of mCFH. In contrast no alpha-chain fragments were evident in glomeruli from Cfi-/- animals. (C) Glomerular C3 staining in mice with combined deficiency of CFH and CFI (Cfh-/-.Cfi-/-) that have been given CFI. Following adminstration of sera containing CFI, linear capillary wall C3 staining develops that is reactive with both the anti-C3 and anti-C3d antibody. Original magnification 40x. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)
###end p 84
###begin p 85
###xml 38 40 38 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 92 94 92 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 217 219 217 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 219 222 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 454 456 454 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 456 459 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 491 493 491 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 493 496 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 624 626 624 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 626 629 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 640 642 640 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 642 645 642 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 832 834 832 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 834 837 834 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 917 919 917 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 919 922 919 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 574 579 <span type="species:ncbi:9606">human</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 838 842 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">mice</span>
Detection of CFH-related proteins in Cfh-/- mice and tracking mCFH after administration to Cfh-/- mice. (A) Serum western blot for CFH using cross-reactive polyclonal anti-human CFH antibody. (B) Renal sections from Cfh-/- mice 2 h after the injection of Alexa-488-tagged CFH. At this time point the Alexa-488-tagged CFH was detected within the mesangium and tubulointerstitium but not along the GBM. At this time-point linear C3 staining is evident in Cfh-/- mice similar to unmanipulated Cfh-/- mice (far right panel). (C) Kidney sections immunostained for CFH using anti-human CFH antibody from wild-type, unmanipulated Cfh-/- mice and Cfh-/- mice 24 h after injection of mCFH. Some mesangial reactivity is present in wild-type glomeruli (left panel) whilst marked linear capillary wall staining is evident in the unmanipulated Cfh-/- mice (middle panel). In contrast, a mesangial staining pattern was evident in Cfh-/- mice 24 h after injection of mCFH (right panel) with very little staining along the capillary walls (arrows). Original magnification, 40x.
###end p 85
###begin p 86
###xml 113 115 113 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 115 118 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 480 483 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cfh</italic>
###xml 483 486 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 718 720 713 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fh</italic>
###xml 720 723 715 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1123 1129 1114 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 442 445 <span type="species:ncbi:10116">rat</span>
###xml 457 462 <span type="species:ncbi:10090">mouse</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 599 602 <span type="species:ncbi:10116">rat</span>
###xml 625 631 <span type="species:ncbi:10090">murine</span>
###xml 724 728 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 899 904 <span type="species:ncbi:10090">mouse</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
Influx of neutrophils into the glomeruli after the administration of mCFH. (A) Glomerular neutrophil numbers in Cfh-/- mice 24 h after injection of PBS, 0.75 mug of LPS or 1 mg of mCFH. Bars denote median values with standard deviation (B) Glomerular neutrophils evident in representative glomerular light microscopic images in mice that had received mCFH but not LPS. Original magnification 40x (C) FACS detection of blood neutrophils using rat IgG2b anti-mouse GR-1 antibody in Cfh-/- mice before, 24 and 48 h after neutrophil depletion. Neutrophil depletion was achieved by a single injection of rat monoclonal IgG2b anti-murine neutrophil Ly.6G (alphaNE). (D) Glomerular neutrophil numbers in neutrophil-depleted Cfh-/- mice 24 h after injection of mCFH demonstrating absence of glomerular neutrophils in mice pre-treated with the alphaNE antibody. (E) Glomerular C3 stain using polyclonal anti-mouse C3 antibody in neutrophil-depleted mice treated with mCFH. The absence of neutrophils did not influence the change in glomerular C3 staining seen after the administration of mCFH. Compare this image with that shown in Fig. 2. Original magnification 40x. WT: wild-type.
###end p 86

